COSI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.078
AS - Asia 291
EU - Europa 279
AF - Africa 1
Totale 3.649
Nazione #
US - Stati Uniti d'America 3.076
SG - Singapore 137
CN - Cina 123
IT - Italia 109
FI - Finlandia 42
SE - Svezia 32
FR - Francia 27
VN - Vietnam 26
GB - Regno Unito 25
DE - Germania 14
NL - Olanda 13
IE - Irlanda 6
CH - Svizzera 5
CZ - Repubblica Ceca 3
IN - India 3
CA - Canada 2
BE - Belgio 1
EG - Egitto 1
KR - Corea 1
PH - Filippine 1
SM - San Marino 1
UA - Ucraina 1
Totale 3.649
Città #
Fairfield 638
Woodbridge 298
Ashburn 283
Seattle 243
Cambridge 224
Houston 215
Chandler 172
Wilmington 166
Ann Arbor 164
Singapore 109
Santa Clara 89
Boardman 66
San Diego 61
Padova 55
Medford 52
Princeton 52
Des Moines 35
Helsinki 29
Dong Ket 26
Roxbury 24
Beijing 9
Nanjing 8
Washington 7
Detroit 6
Dublin 6
Hefei 6
London 6
Hebei 5
Jinan 5
Dronten 4
Milan 4
New York 4
Norwalk 4
Shenyang 4
Cervignano del Friuli 3
Dallas 3
Jiaxing 3
Kunming 3
Mainz 3
Monselice 3
Nanchang 3
Ningbo 3
Olomouc 3
Tianjin 3
Zurich 3
Angri 2
Borås 2
Castellammare di Stabia 2
Changsha 2
Chengdu 2
Chicago 2
Chiswick 2
Chongqing 2
Haikou 2
Ivrea 2
Los Angeles 2
Monza 2
New Bedfont 2
Ogden 2
Orbetello 2
Ottawa 2
Paris 2
Pescara 2
Spinea 2
Zhengzhou 2
Acton 1
Ancona 1
Borgo Maggiore 1
Buffalo 1
Chennai 1
Delhi 1
Duino-Aurisina 1
Fulham 1
Groningen 1
Kharkiv 1
Ma'anshan 1
Monmouth Junction 1
Orange 1
Paranaque City 1
Perugia 1
Phoenix 1
Redwood City 1
Rockville 1
Rome 1
Sarno 1
Shaoxing 1
Solofra 1
South Gate 1
Southwark 1
Trentola-Ducenta 1
Ürümqi 1
Totale 3.178
Nome #
Thrombotic risk correlates with mutational status in true-essential thrombocythemia 133
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 129
Systemic mastocytosis and essential thrombocythemia: Case report and literature overview 126
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations 125
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma 106
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 102
The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance 102
Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study 101
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 97
Complex History of the Discovery and Characterization of Congenital Factor X Deficiency. 96
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 93
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 93
Effect of busulfan on JAK2V617F allele burden. 92
Idiopathic erythrocytosis: a study of a large cohort with a long follow-up 91
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 91
Thrombotic Events in Asymptomatic FXII Deficiency versus Symptomatic FXI Deficiency: Surprising Observations. 90
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 89
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX) 89
Thrombotic and hemorrhagic complications in idiopathic erythrocytosis 85
HFE mutations in idiopathic erythrocytosis 85
Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery 81
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 81
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 81
Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period 80
The story of serum prothrombin conversion accelerator, proconvertin, stable factor, cothromboplastin, prothrombin accelerator or autoprothrombin I, and their subsequent merging into factor VII 76
Antibiotic use and associated factors in a large sample of hospitalised older people 73
Drug-Induced Thrombophilic or Prothrombotic States: An Underestimated Clinical Problem That Involves Both Legal and Illegal Compounds 72
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 72
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 67
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 61
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 61
African and African-American Contribution to the Knowledge of the FVII Padua (Arg304Gln) Defect 53
Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome 51
Acquired Isolated FVII Deficiency An Underestimated and Potentially Important Laboratory Finding. 50
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched vs 128 unaffected family members, during a long sequential observation period (23.5 years). 47
Factor X Friuli coagulation disorder: Almost 50 Years Later 47
Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed 43
A comment on congenital prothrombin abnormalities associated with thrombosis but not with bleeding 43
A structure–function analysis in patients with prekallikrein deficiency 41
Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study 41
Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period* 40
New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice 40
Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation 38
Myocardial Infarctions and Other Acute Coronary Syndromes in Rare Congenital Bleeding Disorders: A Critical Analysis of All Reported Cases. 36
Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions 35
null 34
Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States 34
Prevalence of hypertension and its complications in congenital Prekallikrein deficiency: analysis of all reported cases and clinical significance. 33
Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis 33
Pulmonary embolism in congenital bleeding disorders: Intriguing discrepancies among different clotting factors deficiencies 32
Cardiovascular diseases in congenital prekallikrein deficiency: Comparison with other chanceassociated morbidities 31
Prethrombotic, prothrombotic, thrombophilic states, hypercoagulable state, thrombophilia etc.: semantics should be respected even in medical papers 28
ERYTHROCYTOSIS AND FAMILIARITY: COEXISTANCE OF MULTIPLE MUTATIONS 20
IDIOPATHIC ERYTHROCYTOSIS WITH THROMBOTIC COMPLICATIONS HAS AN ALTERED BIOMOLECULAR PROFILE 20
Ischemic strokes in congenital bleeding disorders: comparison with myocardial infarction and other acute coronary syndromes 19
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 17
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 9
null 9
Totale 3.744
Categoria #
all - tutte 16.176
article - articoli 15.900
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020587 0 0 0 0 71 44 64 100 142 57 95 14
2020/2021870 80 29 70 32 13 16 12 77 148 73 102 218
2021/2022651 3 35 52 62 43 108 10 66 67 26 32 147
2022/2023378 102 14 5 24 76 44 1 36 44 13 16 3
2023/2024287 11 37 48 29 17 37 14 12 8 5 21 48
2024/2025347 4 73 57 52 161 0 0 0 0 0 0 0
Totale 3.744